Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Cytokines for Metastatic Melanoma
NCT02350972Phase 1Completed
- Sponsor
- NYU Langone Health
- Start
- Jul 1978
- Primary completion
- May 2002
01
Overview
Phase 1, open-label, single-arm trial in melanoma, sponsored by NYU Langone Health. Primary endpoint: Immune responses as evidenced by lymphocytic infiltrates in never-injected nodules at 20 weeks. Started Jul 1978; status: completed.
02
Conditions
melanoma
Beyond the preview
Go deeper on NCT02350972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02350972.